PROM1 and non-small cell lung carcinoma: ALDH and CD133 are considered as classical and reliable biomarkers of CSCs in NSCLC.18 To further substantiate the results found in CDDP-treated NSCLC cells, we detected the effects of pretreatment with CDDP on ALDH and CD133 in NSCLC cells.